Header Logo

Douglas Thornton

TitleAssistant Professor
InstitutionUniversity of Houston
DepartmentPharmaceutical Health Outcomes and Policy
Address4800 Calhoun Rd
Houston TX 77004
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Anyanwu P, Olateju OA, Tata V, Varisco T, Gilbert LR, Ogunsanya ME, Essien EJ, Johnson ML, Thornton JD. Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study. Harm Reduct J. 2024 Dec 20; 21(1):220. PMID: 39707438; PMCID: PMC11660775.
      Citations:    Fields:    Translation:Humans
    2. Olateju OA, Li J, Thornton JD, Aparasu RR. Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374. PMID: 39612258; PMCID: PMC11607212.
      Citations:    Fields:    Translation:Humans
    3. Winstanley EL, Gray A, Thornton D. Addressing the Escalating Problems That Patients Encounter When Filling Buprenorphine Prescriptions. JAMA Psychiatry. 2024 Dec 01; 81(12):1167-1168. PMID: 39412773.
      Citations:    Fields:    
    4. Olateju OA, Mgbere O, Thornton JD, Zeng Z, Essien EJ. Disparities in Survival Outcomes Among Patients With Metastatic Melanoma in Texas: Implications for Policy and Interventions in the Era of Immune Checkpoint Inhibitors. Am J Clin Oncol. 2024 Nov 01; 47(11):517-525. PMID: 38937888.
      Citations:    Fields:    Translation:Humans
    5. Varisco TJ, Fish H, Bolin J, Dadiomov D, Hill LG, Essien EJ, Wanat MA, Ginsburg D, Waggener J, Yazdanfard S, Song J, Chi W, Thornton D. Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy. Arch Public Health. 2024 Apr 25; 82(1):58. PMID: 38664777; PMCID: PMC11044383.
      Citations:    
    6. Chi W, Okeke C, Thornton D, Chen H, Sadeghi A, Varisco TJ. Leveraging prescription monitoring program data to evaluate the implementation of buprenorphine telehealth flexibilities: An interrupted time series analysis in Texas. Drug Alcohol Depend Rep. 2024 Mar; 10:100222. PMID: 38463634; PMCID: PMC10920117.
      Citations:    
    7. Shen C, Thornton JD, Li N, Schaefer E, Zhou S, Kawasaki S, Pameijer C, Leslie D. Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184. PMID: 37944042; PMCID: PMC10836308.
      Citations:    Fields:    Translation:Humans
    8. Yazdanfard S, Thornton D, Bhatt P, Fatima B, Khalid J, Song J, Varisco TJ. Regional Variation in Opioid-Related Emergency Medical Services Transfers During the COVID-19 Pandemic: An Interrupted Time Series Analysis. Subst Use Addctn J. 2024 Jan; 45(1):74-80. PMID: 38258862.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Thornton JD, Varisco T, Bhatt M Econ P, Olateju O, Shrestha M, Shen C. Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 Mar 01; 66(3):226-233. PMID: 38151973; PMCID: PMC10922134.
      Citations:    Fields:    Translation:Humans
    10. Tata V, Al Saadi R, Cho SK, Varisco TJ, Wanat M, Thornton JD. Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC Health Serv Res. 2023 Oct 31; 23(1):1185. PMID: 37907915; PMCID: PMC10617230.
      Citations:    Fields:    Translation:Humans
    11. Wang EM, Varisco TJ, Thornton JD, Varkey DA, Wanat MA. Student-led podcasts to enhance literature evaluation skills. Curr Pharm Teach Learn. 2023 Nov; 15(11):968-973. PMID: 37714755.
      Citations:    Fields:    
    12. Olateju OA, Zeng Z, Thornton JD, Mgbere O, Essien EJ. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655. PMID: 37442992; PMCID: PMC10339559.
      Citations:    Fields:    Translation:Humans
    13. Tata V, Majd Z, Talwar A, Bapat S, Cruz A, Essien JE, Thornton JD. Differences in Perceived Threat and Efficacy in Managing Opioid Use Disorder versus Alcohol Use Disorder. Subst Use Misuse. 2023; 58(10):1187-1195. PMID: 37271735.
      Citations:    Fields:    Translation:Humans
    14. Varisco T, Patel H, Saadi RA, Wanat M, Thornton D. Patients prefer free drug disposal options delivered by pharmacists at the point of care: Results of a decision tree analysis of a national factorial vignette panel survey. Int J Drug Policy. 2023 06; 116:104045. PMID: 37156066.
      Citations: 3     Fields:    Translation:Humans
    15. Al Rawwad T, Tata V, Wanat MA, Campbell D, Thornton D. Evaluating the feasibility of implementing a prescription drug misuse prevention intervention in the community: a mixed methods study. BMC Public Health. 2023 04 21; 23(1):728. PMID: 37085838; PMCID: PMC10120215.
      Citations:    Fields:    Translation:Humans
    16. El-Desoky R, De La Cruz A, Thornton JD, Wanat MA, Varkey D. Identifying predictors of generalized anxiety among student pharmacists in response to the COVID-19 pandemic. Curr Pharm Teach Learn. 2023 01; 15(1):34-42. PMID: 36898886; PMCID: PMC9970934.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    17. Rizk E, Yuan F, Zheng F, Fink E, Kaur N, Tran AT, Iso T, Mohyuddin NG, Thekdi AA, Jackson GL, Wanat MA, Thornton JD, Swan JT. Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgery. Otolaryngol Head Neck Surg. 2023 Jul; 169(1):176-184. PMID: 36040827.
      Citations:    Fields:    Translation:Humans
    18. Huang Y, Lyu N, Gohil S, Bapat S, Essien EJ, Thornton JD. Intention to get naloxone among?patients prescribed opioids for chronic pain. Harm Reduct J. 2022 Sep 22; 19(1):104. PMID: 36138420; PMCID: PMC9502607.
      Citations:    Fields:    Translation:Humans
    19. Bapat S, Washburn M, Tata V, Fleming M, Abughosh SM, Essien EJ, Thornton D. Barriers and Facilitators to DATA Waivered Providers Prescribing Buprenorphine: A Qualitative Analysis Applying the Theory of Planned Behavior. Subst Use Misuse. 2022; 57(12):1761-1771. PMID: 35993387.
      Citations: 1     Fields:    Translation:Humans
    20. Al Rawwad T, Schrader PK, Brooks A, Duong L, Thornton D. Do nursing and pharmacy students practice what they preach on safe drug storage and disposal? A cross-sectional study. Nurse Educ Today. 2021 Dec; 107:105143. PMID: 34583239.
      Citations: 4     Fields:    Translation:Humans
    21. Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR. Factors associated with oral fingolimod use over injectable disease- modifying agent use in multiple sclerosis. Explor Res Clin Soc Pharm. 2021 Jun; 2:100021. PMID: 35481133; PMCID: PMC9031432.
      Citations: 1     
    22. Earla JR, Hutton GJ, Thornton DJ, Chen H, Johnson ML, Aparasu RR. Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis. Pharmacotherapy. 2021 05; 41(5):440-450. PMID: 33641232.
      Citations:    Fields:    Translation:Humans
    23. Iloabuchi C, Aboaziza E, Zhao X, Thornton JD, Dwibedi N. College Students' Perceptions About Prescription Drug Misuse Among Peers. Am Health Drug Benefits. 2021 Mar; 14(1):29-38. PMID: 33841623; PMCID: PMC8025926.
      Citations: 1     
    24. Shen C, Thornton JD, Newport K, Schaefer E, Zhou S, Yee NS, Dodge D, Leslie D. Trends and patterns in the use of opioids among metastatic breast cancer patients. Sci Rep. 2020 Dec 10; 10(1):21698. PMID: 33303832; PMCID: PMC7729956.
      Citations: 6     Fields:    Translation:Humans
    25. Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR. Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis. Patient Prefer Adherence. 2020; 14:2187-2199. PMID: 33177813; PMCID: PMC7649232.
      Citations: 5     
    26. Wanat MA, Varkey DA, Sulaica EM, Thornton KA, Thornton JD. Does Social Desirability Influence Preceptors' Completion of Student Experiential Evaluations? Am J Pharm Educ. 2020 09; 84(9):ajpe7949. PMID: 33012802; PMCID: PMC7523664.
      Citations: 1     Fields:    Translation:Humans
    27. Varisco TJ, Johnson ML, Thornton D. Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Int J Infect Dis. 2020 10; 99:373. PMID: 32771630; PMCID: PMC7409789.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    28. Varisco T, Shen C, Thornton D. Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorder. J Subst Abuse Treat. 2020 10; 117:108073. PMID: 32811630; PMCID: PMC7451120.
      Citations: 3     Fields:    Translation:Humans
    29. Varisco TJ, Downs CG, Rathburn KR, Fleming ML, Thornton JD. Applying the capability, opportunity, motivation, and behavior model to identify opportunities to increase pharmacist comfort dispensing naloxone in Texas: A structural equation modeling approach. Int J Drug Policy. 2020 09; 83:102827. PMID: 32589581.
      Citations: 4     Fields:    Translation:Humans
    30. Earla JR, Hutton GJ, Thornton JD, Aparasu RR. Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334. PMID: 32629400.
      Citations: 1     Fields:    Translation:Humans
    31. Downs CG, Varisco TJ, Bapat SS, Shen C, Thornton JD. Impact of COVID-19 related policy changes on filling of opioid and benzodiazepine medications. Res Social Adm Pharm. 2021 01; 17(1):2005-2008. PMID: 33317769; PMCID: PMC7738763.
      Citations: 8     Fields:    Translation:Humans
    32. Shen C, Thornton JD, Gu D, Dodge D, Zhou S, He W, Zhao H, Giordano SH. Prolonged Opioid Use After Surgery for Early-Stage Breast Cancer. Oncologist. 2020 Oct; 25(10):e1574-e1582. PMID: 32390251; PMCID: PMC7543235.
      Citations: 4     Fields:    Translation:Humans
    33. Earla JR, Thornton JD, Hutton GJ, Aparasu RR. Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749. PMID: 32463779; PMCID: PMC10391019.
      Citations: 6     Fields:    Translation:Humans
    34. Adil MQ, De La Cruz A, Thornton JD, Wanat MA. Incidence of Chronic Opioid Use in Previously Opioid-Na?ve Patients Receiving Opioids for Analgesia in the Intensive Care Unit. Fed Pract. 2020 Apr; 37(4):170-176. PMID: 32322148; PMCID: PMC7173643.
      Citations: 2     
    35. Thornton JD, Anyanwu P, Tata V, Al Rawwad T, Fleming ML. Differences between pharmacists' perception of counseling and practice in the era of prescription drug misuse. Pharm Pract (Granada). 2020; 18(1):1682. PMID: 32206140; PMCID: PMC7075424.
      Citations: 4     
    36. Stover AN, Grogg K, Patel J, Thornton D, Dwibedi N. Opioid Overdose Knowledge among College Students in a High Overdose Death State. J Hum Behav Soc Environ. 2019; 29(7):887-896. PMID: 32952392; PMCID: PMC7500461.
      Citations: 2     
    37. Thornton D, Dwibedi N, Scott V, Ponte CD, Tan XI, Ziedonis D, Sambamoorthi U. Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid Therapy. Am J Accountable Care. 2018 Dec; 6(4):11-18. PMID: 34124532; PMCID: PMC8194048.
      Citations: 2     
    38. Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U. Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States. Am Health Drug Benefits. 2018 Feb; 11(1):12-21. PMID: 29692877; PMCID: PMC5902762.
      Citations: 11     
    Thornton's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (111)
    Explore
    _
    Co-Authors (11)
    Explore
    _
    Same Department Expand Description
    Explore
    _